vigabatrin

Generic: vigabatrin

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name vigabatrin
Generic Name vigabatrin
Labeler zydus lifesciences limited
Dosage Form POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients

vigabatrin 500 mg/10mL

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1742
Product ID 70771-1742_2fd46d14-d59a-4335-9f92-9e029defc7b2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214671
Listing Expiration 2026-12-31
Marketing Start 2025-03-24

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711742
Hyphenated Format 70771-1742

Supplemental Identifiers

RxCUI
250820
UNII
GR120KRT6K
NUI
N0000175753

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vigabatrin (source: ndc)
Generic Name vigabatrin (source: ndc)
Application Number ANDA214671 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/10mL
source: ndc
Packaging
  • 50 PACKET in 1 CARTON (70771-1742-8) / 10 mL in 1 PACKET (70771-1742-1)
source: ndc

Packages (1)

Ingredients (1)

vigabatrin (500 mg/10mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2fd46d14-d59a-4335-9f92-9e029defc7b2", "openfda": {"nui": ["N0000175753"], "unii": ["GR120KRT6K"], "rxcui": ["250820"], "spl_set_id": ["cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26c"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 PACKET in 1 CARTON (70771-1742-8)  / 10 mL in 1 PACKET (70771-1742-1)", "package_ndc": "70771-1742-8", "marketing_start_date": "20250324"}], "brand_name": "vigabatrin", "product_id": "70771-1742_2fd46d14-d59a-4335-9f92-9e029defc7b2", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]"], "product_ndc": "70771-1742", "generic_name": "vigabatrin", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "vigabatrin", "active_ingredients": [{"name": "VIGABATRIN", "strength": "500 mg/10mL"}], "application_number": "ANDA214671", "marketing_category": "ANDA", "marketing_start_date": "20250324", "listing_expiration_date": "20261231"}